If you want to receive trading signals - like these in real time - register on the platform and buy the Pro version of LargeTrader.
Good Morning Traders,
With the close of November 23, Lift-Off offers a LONG trading signal on the U.S. stock Teleflex Inc (Ticker: TFX) listed on the NYSE and part of the S&P500 Index.
The stock closed at USD 225.71 per share, marking a +4.01%.
The company operates in the "Health Technology" sector particularly in the "Medical Specialties Industry"
Financial robustness figures are good, but the Cash-To-Debt figure is 0.22 the WACC vs ROIC is slightly negative, ROIC however positive, The financial stress indicators are not very positive.
The profitability level data is very high, the data compared to companies in the same industry is good, and also compared to its past, the ROE positive.
The 3-year future projection is seen to be upward compared to current prices.
Right now the price is extremely undervalued relative to the intrinsic value attributed to it, but at this time of probable recession this sector could see a price uptick.
Year-over-year sales are up with a slight decline seen in 2020, net income steadily increasing since 2018, with a negative year in 2020. Makes Q3'22 slightly down from Q2'22 (up on Q1'22, but down YoY).
Net income is down slightly on previous reading and down sharply YoY with a -48.84%
Debt down 30.21% in 2021 after peaking in 2020. In Q3'22 net debt decreased by -6.76% to US$1.41B with a decrease of US$102.31M
Cash flow (FCF) increasing YoY, with a slight decrease recorded in 2019, but in 2021 the company recorded a 67.56% increase in cash. In Q3'22 it had a marked increase in FCF compared to previous quarters but a decrease of -28.01% YoY.
Next earnings announcement for Q4 2022: February 23, 2023
Q3 2022 Results
EPS: Reported 3.27 / Expected 3.11 / previous 3.39
Earnings: Reported 686.79M / Expected 691.53M / previous 704.54M
Below chart of Teleflex Inc - TFX - with signal detected by Lift-Off
Some information about Teleflex Inc
Teleflex, Inc. provides medical technology products that enable healthcare providers to improve patient outcomes and enhance patient and caregiver safety.
The company designs, develops, manufactures and supplies disposable medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
In the Americas it engages in the sale of interventional urology products, EMEA engages in the sale of urology products, in Asia it designs, manufactures, and distributes medical devices used primarily in critical care, surgical applications, and cardiac care and generally serves hospitals and health care providers, and OEM designs, manufactures, and supplies devices and instruments for other medical device manufacturers.
The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Financial Overview: TFX's current market capitalization is $10,179B USD. The company's TTM EPS is 8.80 USD, dividend yield is 0.63% and PE is 24.57. Teleflex Incorporated's next earnings release date is Feb. 23. The estimate is US$3.44.
Accounts, including revenue, expenses, profit and loss: TFX's total revenue for the latest quarter is US$686.79M, down 2.52% from the previous quarter. Net income in Q3 22 is 101.89M USD.
Overview data and accounts source: Tradingview.com
Signal board of November 24, 2022
LONG - Teleflex Inc - TFX
Input price: 225.71 USD (and any opening price)